This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Translational Prostate Cancer
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Clinical Trials
From the Editor
Search Clinical Trials
Trials in Progress
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Oral EPI-7386
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2022
ASCO GU 2023
EAU 2023
All Conferences
View All
PCF
UroToday Home
Video Lectures
ASCO GU 2023 Videos
The Phase 1B NABUCCO Trial: The Use of Either High or Low-Dose Preoperative Ipilimumab plus Nivolumab in Patients with Stage III Urothelial Cancer – Michiel Van Der Heijden
March 28, 2023
Details
Extended Follow-Up Results of the CheckMate 274 Trial: Adjuvant Nivolumab for Resected Muscle-Invasive Urothelial Carcinoma - Matthew Galsky
March 27, 2023
Details
Neoadjuvant Versus Adjuvant Chemotherapy in Patients With Clinically Node-positive UTUC Who Underwent a Radical Nephroureterectomy - Karan Jatwani
March 27, 2023
Details
The Role of Adjuvant Chemotherapy, Versus Observation, in Patients With Upper Urinary Tracts With Variant Histology Undergoing a Radical Nephroureterectomy - Karan Jatwani
March 27, 2023
Details
Advances in Advanced Prostate Cancer - Silke Gillessen
March 24, 2023
Details
Long-Term Follow-up from the JAVELIN Bladder 100 Trial - Srikala Sridhar
March 24, 2023
Details
Testosterone Recovery in Patients With Prostate Cancer Treated With Radiotherapy Plus ADT - Tanya Dorff
March 24, 2023
Details
Brain Metastases From Renal Cell Carcinoma Treated With First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium - Kosuke Takemura
March 23, 2023
Details
Overall Survival and Efficacy Results of Second-line Treatment for Patients With Metastatic Clear Cell Renal Cell Carcinoma, BIONIKK Trial -Yann Vano
March 23, 2023
Details
Real-world Experiences Associated with Treating Patients With Lutetium-177 PSMA in a High-volume Care Center - Thomas Hope
March 22, 2023
Details
A Novel Patient-reported Outcome Measure for Patients With Prostate Cancer Receiving Radionuclide Therapy: FACT-RNT - Lisa Gudenkauf
March 22, 2023
Details
Fractionated 225Ac-J591 for Progressive mCRPC in Patients with Prior Treatment with 177Lu-PSMA - Jones Nauseef
March 22, 2023
Details
An Integrative Platform of Whole Genome and Transcriptome Sequencing to Identify Additional Targets in Advanced Prostate Cancer - Jones Nauseef
March 22, 2023
Details
3-Year Follow-up CheckMate 9ER Trial: Nivolumab plus Cabozantinib vs Sunitinib for First-Line Treatment of Advanced Renal Cell Carcinoma - Mauricio Burotto
March 21, 2023
Details
CaboPoint Study: Cabozantinib After Checkpoint Inhibitor Therapy in Patients with Advanced Renal Cell Carcinoma - Laurence Albiges
March 20, 2023
Details
Cabozantinib in Combination with Atezolizumab in Non-Clear Cell Renal Cell Carcinoma: Extended Follow-up Results of Cohort 10 of the COSMIC-021 Study - Bradley McGregor
March 20, 2023
Details
BXCL701 Combined with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer of Small Cell Neuroendocrine Phenotype - Rahul Aggarwal
March 20, 2023
Details
Novel Antiandrogens Added to ADT Improves Outcomes in a Subset of High Risk Prostate Cancer Patients - Paul Ngueyn
March 19, 2023
Details
Results from Cohort B of the Phase 2 KEYNOTE-057 Trial, Pembrolizumab Monotherapy for Patients with High-Risk Non–muscle-Invasive Bladder Cancer Unresponsive to BCG - Andrea Necchi
March 16, 2023
Details
Results from the Phase 1b/2 FIDES-02 Study: Derazantinib for Metastatic Bladder Cancer with Activating FGFR1/2/3 Genetic Aberrations - Andrea Necchi
March 16, 2023
Details
Neoadjuvant Nivolumab and Ipilimumab for Upper Tract Urothelial Cancer - Min Yuen Teo
March 8, 2023
Details
A SEER-Medicare Based Quality Score for Patients with Both Synchronous and Metachronous Metastatic Upper Tract Urothelial Carcinoma - Daniel Joyce
March 8, 2023
Details
Efficacy and Safety of Darolutamide in Combination with ADT and Docetaxel by Disease Volume and Disease Risk in the ARASENS Trial - Karim Fizazi
March 5, 2023
Details
Safety and Disease Related Outcomes of mCRPC Patients Who Were Treated with Radium-223 Then 177Lu-PSMA (RALU) - Neal Shore
March 5, 2023
Details
Delaying Time to Metastasis in Patients With High-Risk, M0 CRPC With Radiolabeled J591 Plus Ketoconazole and Hydrocortisone - Scott Tagawa
March 4, 2023
Details
The Combination of Enzalutamide Plus Talazoparib for Patients With Castration-Sensitive Metastatic Prostate Cancer With HRR Gene Alterations (TALAPRO-3) - Neeraj Agarwal
March 4, 2023
Details
The Association Between the Time Interval Between Sequential Treatment With Radium-223 Therapy and 177Lu-PSMA in the RALU Study - Kambiz Rahbar
March 3, 2023
Details
Phase 1/2 Study of EPI-7386 in Combination with Enzalutamide in Metastatic Castration-Resistant Prostate Cancer- Andrew Laccetti
March 3, 2023
Details
Oral EPI-7386 Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Russell Pachynski
March 3, 2023
Details
Final Overall Survival Results from the PROpel Phase 3 Trial in First-line Therapy for mCRPC - Fred Saad
March 3, 2023
Details
Extended Follow-Up Results CheckMate 274 Trial and Results of Pembrolizumab Monotherapy in BCG-Unresponsive HR NMIBC: Findings from Cohort B of the KEYNOTE-057 Trial - Michiel Van der Heijden
March 28, 2023
Details
The Benefit of the Addition of Talazoparib to Enzalutamide in First Line Treatment for mCRPC TALAPRO-2 - Neeraj Agarwal
March 2, 2023
Details
PARP Inhibitors in Metastatic Castration Resistant Prostate Cancer - Elena Castro
March 1, 2023
Details
Phase 3 ARASENS Study, The Impact of Disease Burden and Risk on Efficacy and Safety Outcomes - Matthew Smith
March 1, 2023
Details
The Role of Neoadjuvant Chemotherapy on Pathological Stage and Survival in Sarcomatoid Bladder Cancer – Arya Roy
February 27, 2023
Details
Reduction in the Risk of Recurrence with the Use of Blue Light Cystoscopy Use Among Patients with Non-Muscle Invasive Bladder Cancer In An Equal Access Setting - Stephen Williams
February 27, 2023
Details
Treating Biochemical Recurrence With Enhanced Therapy Added to Standard of Care and Targeted Radiation Using PET/CT Imaging, ECOG-ACRIN EA8191 (INDICATE) - Neha Vapiwala
February 24, 2023
Details
TROPHY-U-01 Cohort 3 Primary Analysis Sacituzumab Govitecan in Combination with Pembrolizumab in Patients with Metastatic Urothelial Cancer That Progressed after Platinum-Based Therapy - Petros Grivas
February 23, 2023
Details
The Future of Immune Checkpoint Inhibitors in the First-Line Treatment of Metastatic Urothelial Carcinoma - Andrea Apolo
February 23, 2023
Details
HCRN GU 16-260, Nivolumab and Salvage Nivolumab+Ipilimumab in Patients with Advanced Renal Cell Carcinoma Cohort A, Treatment-Free Survival Outcomes - Michael Atkins
February 22, 2023
Details
Cell-Free Urinary DNA Predictive Impact on Patients with Non-Muscle Invasive Bladder Cancer - Kyle Rose
February 22, 2023
Details
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
